With a team of more than 140 people and over a decade’s experience, the expanded ZeinCRO Group will be ideally positioned to offer to its global drug development customers clinical trial services in a broader geographical region in Central and South- Eastern Europe (CSEE).
“Adding Trial Masters to ZeinCRO Group will extend our geographic reach and allow us to work on larger-scale projects,” said Gregory Sivolapenko, chairman of ZeinCRO Group. “Both our teams have forged strong links with local authorities and the healthcare community, giving us a unique and in-depth understanding of the regions in which we operate and enabling us to deliver bespoke clinical research services that are flexible and ethical, maximizing patient recruitment and compliance.”
Supplementary to clinical research services in CSEE, ZeinCRO Group provides specialized services in risk management plans, pharmacovigilance, post-marketing safety and efficacy studies as well as regulatory affairs.
Dr. János Demeter, CEO of Trial Masters, added, “We are excited to be joining ZeinCRO Group. This is a natural fit as we both share the same core values and fundamental approach to successfully delivering clinical development programs. As we continue our local presence but also become part of a larger organization, we will be able to enhance the support we offer to our customers.”